Compound heterozygous mutations in electron transfer flavoprotein dehydrogenase identified in a young Chinese woman with late-onset glutaric aciduria type II
Open Access
- 26 September 2017
- journal article
- case report
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 16 (1) , 185
Abstract
Glutaric aciduria type II (GA II) is an autosomal recessive disorder affecting fatty acid and amino acid metabolism. The late-onset form of GA II disorder is almost exclusively associated with mutations in the electron transfer flavoprotein dehydrogenase (ETFDH) gene. Till now, the clinical features of late-onset GA II vary widely and pose a great challenge for diagnosis. The aim of the current study is to characterize the clinical phenotypes and genetic basis of a late-onset GAII patient. In this study, we described the clinical and biochemical manifestations of a 23-year-old female Chinese patient with late-onset GA II, and performed genomic DNA-based PCR amplifications and sequence analysis of ETFDH gene of the whole pedigree. We also used in-silicon tools to analyze the mutation and evaluated the pathogenicity of the mutation according to the criteria proposed by American College of Medical Genetics and Genomics (ACMG). The muscle biopsy of this patient revealed lipid storage myopathy. Blood biochemical test and urine organic acid analyses were consistent with GA II. Direct sequence analysis of the ETFDH gene (NM_004453) revealed compound heterozygous mutations: c.250G > A (p.A84T) on exon 3 and c.920C > G (p.S307C) on exon 8. Both mutations were classified as “pathogenic” according to ACMG criteria. In conclusion, our study described the phenotype and genotype of a late-onset GA II patient, reiterating the importance of ETFDH gene screening in these patients.Keywords
Funding Information
- National Natural Science Foundation of China (81400834, 81500589, 81570799)
This publication has 21 references indexed in Scilit:
- Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2Current Protocols in Human Genetics, 2013
- Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motifBMC Structural Biology, 2011
- High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late‐onset lipid storage myopathyClinical Genetics, 2010
- Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutationsJournal of Neurology, Neurosurgery & Psychiatry, 2009
- ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiencyNeuromuscular Disorders, 2009
- ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiencyBrain, 2007
- Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone poolProceedings of the National Academy of Sciences, 2006
- Lipid‐storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late‐onset multiple acyl‐CoA dehydrogenation deficiencyJournal of Inherited Metabolic Disease, 2004
- Multiple sequence alignment with the Clustal series of programsNucleic Acids Research, 2003
- Clear relationship betweenETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiencyHuman Mutation, 2003